1001
|
|
|
Peroxiredoxin 4 |
AOE37-2, AOE372, HEL-S-97n, PRX-4 |
|
1002
|
|
|
Peroxiredoxin 5 |
ACR1, AOEB166, B166, HEL-S-55, PLP, PMP20, PRDX6, PRXV, SBBI10, prx-V |
Attention deficit hyperactivity disorder, Basal cell carcinoma, Crohn disease, Hypothyroidism, Iga nephropathy, Inflammatory bowel disease, Multiple sclerosis, Non-melanoma skin carcinoma, Biliary cholangitis, Psoriasis, Psoriasis vulgaris, Rheumatoid arthritis, Sarcoidosis, Skin cancer, Skin neoplasms, Stomach neoplasms, Substance abuse, Diabetes mellitus type 2, Ulcerative colitisView all (4 more) |
1003
|
|
|
Peroxiredoxin 6 |
1-Cys, AOP2, HEL-S-128m, LPCAT-5, NSGPx, PRX, aiPLA2, p29 |
|
1004
|
|
|
PRELI domain containing 1 |
CGI-106, PRELI, PX19, SBBI12 |
|
1005
|
|
|
PRELI domain containing 2 |
- |
|
1006
|
|
|
PRELI domain containing 3A |
C18orf43, HFL-EDDG1, SLMO1 |
|
1007
|
|
|
PRELI domain containing 3B |
C20orf45, SLMO2, UPS2, dJ543J19.5 |
|
1008
|
|
|
Proline and arginine rich end leucine rich repeat protein |
MST161, MSTP161, SLRR2A |
|
1009
|
|
|
Prolyl endopeptidase |
PE, PEP |
|
1010
|
|
|
Prolyl endopeptidase like |
CMS22 |
|